Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Assessment of Grazax® Treatment Compliance

This study has been completed.
Information provided by:
ALK-Abelló A/S Identifier:
First received: February 16, 2006
Last updated: September 29, 2008
Last verified: September 2008
No Study Results Posted on for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2007
  Primary Completion Date: September 2006 (Final data collection date for primary outcome measure)